Imunopharm Technology Co., Ltd.
PrivateLast Round
Series E
Jan 8, 2025
Est. Valuation
$517.17M
Total Funding Raised
$97.1M
Company Overview
Imunopharm Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series E round in January 2025.
Imunopharm Technology Co., Ltd. is a biopharmaceutical company that develops innovative cell and gene therapies to treat serious diseases such as cancer and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imunopharm Technology Co., Ltd. Comparables
Compare Imunopharm Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hrain Biotechnology Co., Ltd. | 91% | |
| Juventas Cell Therapy Ltd. | 87% | |
| IASO Bio | 84% |
For institutional investors. Book with your work email.
Imunopharm Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jan 8, 2025 | ||||
| Series D Extension | Oct 31, 2022 | ||||
| Series D | Nov 24, 2021 | ||||
| Series C Extension | Dec 22, 2020 | ||||
| Series C Extension | Oct 19, 2020 | ||||
Series C | Jan 22, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Imunopharm Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thiel Capital | Series B, Series A |
| Legend Capital | Series B |
| Beijing Zhongguancun Science City Innovation Development Co., Ltd. | Series D Extension |
| China Taiping Insurance Group | Series E |
| 北京首都科技发展集团有限公司 | Series E, Series A |
| SDIC Venture Capital | Series E, Series D, Series C Extension |
| 太平医疗健康基金 | Series E |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 26, 2025
Monthly visitors increased 52% MoM, from 355 to 539.
- Oct 1, 2024
Grew 29% QoQ, from 14 to 18 employees.
For institutional investors. Book with your work email.
Imunopharm Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Imunopharm Technology Co., Ltd.'s valuation, stock price, and market status.
Is Imunopharm Technology Co., Ltd. a public or private company?
Imunopharm Technology Co., Ltd. is a private company.
What is the current stock price of Imunopharm Technology Co., Ltd.?
Imunopharm Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Imunopharm Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Imunopharm Technology Co., Ltd. worth (valuation)?
Imunopharm Technology Co., Ltd.'s valuation is estimated at $517.2M based on funding round data.
Can I buy Imunopharm Technology Co., Ltd. stock?
Imunopharm Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Imunopharm Technology Co., Ltd.'s last funding round?
Imunopharm Technology Co., Ltd.'s most recent funding round was Series E on January 8, 2025.
Who are the main investors in Imunopharm Technology Co., Ltd.?
Key investors in Imunopharm Technology Co., Ltd. include Legend Capital, Beijing Zhongguancun Science City Innovation Development Co., Ltd..
Will Imunopharm Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Imunopharm Technology Co., Ltd..
How can I track Imunopharm Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Imunopharm Technology Co., Ltd.'s shares on secondary markets.